Amedisys Inc (AMED) Receives Price Target

Amedisys Inc (AMED) : Average target price received by Amedisys Inc (AMED) is $54.71 with an expected standard deviation of $3.73. The most aggressive target on the stock is $59, whereas the most downbeat target is $48. 7 financial analysts are currently covering the stock.

Amedisys Inc (AMED) : The consensus on Amedisys Inc (AMED) based on 9 analyst recommendation on the company stock is 2.11, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 4 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.


Also, Major Brokerage house, Mizuho Securities downgrades its ratings on Amedisys Inc (NASDAQ:AMED). According to the latest information available, the shares are now rated Neutral by the analysts at the agency. Previously, the analysts had a Buy rating on the shares. The rating by the firm was issued on August 3, 2016.

Amedisys Inc (NASDAQ:AMED): The stock opened at $48.13 on Thursday but the bulls could not build on the opening and the stock topped out at $48.53 for the day. The stock traded down to $47.66 during the day, due to lack of any buying support eventually closed down at $48.10 with a loss of -0.06% for the day. The stock had closed at $48.13 on the previous day. The total traded volume was 245,651 shares.

Amedisys, Inc. (Amedisys) is a health care at home company. Amedisys delivers home health and hospice care to more than 360,000 patients each year. The Company has care network across 34 states. As of December 31, 2014, it owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers. The Company operates through two segments: home health and hospice. The Companys home health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with the essential activities of daily living. The Companys hospice segment provides palliative care and comfort to terminally ill patients and their families.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.